ONCOMINE MYELODYSPLASTIC SYNDROMEMDS PANEL Test
Test Name: ONCOMINE MYELODYSPLASTIC SYNDROMEMDS PANEL Test
Test Components: ASXL1, BCOR, CBL, CEBPA, DNMT3A, EZH2, ETV6, FLT3, GATA2, HRAS, IDH1, IDH2, IKZF1, JAK2, KIT, KRAS, MECOM, MYC, MPL, NRAS, NF1, NPM1, PHF6, PPRF8, PTPN11, PHF6, RUNX1, SF3B1, SRSF2, SMC1A, SH2B3, STAG2, TP53, TET2, U2AF1, WT1, ZRSR2
FUSION GENE: ETV6, JAK2, KMT2A, MLL, MECOM, RARA, RUNX1
Price: 8190.0 AED
Sample Condition: 3 mL (2 mL min.) whole Blood OR Bone Marrow in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled NGS Test Requisition Form is mandatory.
Report Delivery: Sample by 1st / 16th of every month; Report 15th / 30th of Same month
Method: NGS (Next Generation Sequencing)
Test Type: Leukemia
Doctor: Hematologist, Oncologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information: Duly filled NGS Test Requisition Form is mandatory.
Test Details
The Oncomine Myelodysplastic Syndrome (MDS) Panel Test is a diagnostic tool used to detect genetic mutations in patients with MDS, a group of disorders in which the bone marrow produces abnormal blood cells. The test analyzes DNA from a patient’s blood or bone marrow sample and identifies mutations in 28 genes that are commonly associated with MDS. These mutations can help doctors make a more accurate diagnosis and determine the best course of treatment for the patient. The Oncomine MDS Panel Test is a non-invasive, fast, and accurate way to diagnose MDS, and it can help patients get the care they need as quickly as possible.
Test Name | ONCOMINE MYELODYSPLASTIC SYNDROMEMDS PANEL Test |
---|---|
Components | ASXL1, BCOR, CBL, CEBPA,DNMT3A, EZH2, ETV6, FLT3, GATA2, HRAS, IDH1, IDH2, IKZF1, JAK2, KIT, KRAS,MECOM, MYC, MPL, NRAS, NF1, NPM1, PHF6, PPRF8, PTPN11,PHF6, RUNX1, SF3B1, SRSF2, SMC1A, SH2B3, STAG2, TP53, TET2, U2AF1, WT1, ZRSR2FUSION GENE -ETV6, JAK2, KMT2A, MLL, MECOM , RARA, RUNX1, |
Price | 8190.0 AED |
Sample Condition | 3 mL (2 mL min.) whole Blood OR Bone Marrow in 1 Lavender top (EDTA) tube. Ship refrigerated. DO NOT FREEZE. Duly filled NGS Test Requisition Formis mandatory. |
Report Delivery | Sample by 1st / 16th of every month; Report 15th / 30th of Same month |
Method | NGS |
Test type | Leukemia |
Doctor | Hematologist, Oncologist |
Test Department: | MOLECULAR DIAGNOSTICS |
Pre Test Information | Duly filled NGS Test Requisition Formis mandatory. |
Test Details | The Oncomine Myelodysplastic Syndrome (MDS) Panel Test is a diagnostic tool used to detect genetic mutations in patients with MDS, a group of disorders in which the bone marrow produces abnormal blood cells. The test analyzes DNA from a patient’s blood or bone marrow sample and identifies mutations in 28 genes that are commonly associated with MDS. These mutations can help doctors make a more accurate diagnosis and determine the best course of treatment for the patient. The Oncomine MDS Panel Test is a non-invasive, fast, and accurate way to diagnose MDS, and it can help patients get the care they need as quickly as possible. |